Skip to main content
. 2017 Jun 8;357:j2499. doi: 10.1136/bmj.j2499

graphic file with name liuj036190.f4.jpg

Fig 4 All cause mortality in patients with type 2 diabetes receiving incretin based treatment versus placebo in large cardiovascular outcomes trials